Kenvue Inc. reported its financial results for the fiscal quarter ending June 29, 2025, revealing a net income of $420 million, a significant increase from $58 million in the same period last year. The company's revenue for the quarter was $3.839 billion, down 4% from $4 billion in the prior year. The decline in sales was attributed to volume-related decreases and unfavorable value realization, particularly in the Self Care and Skin Health and Beauty segments, which faced challenges from softer seasonal demand and trade inventory fluctuations.

In terms of profitability, Kenvue's operating income rose to $692 million from $154 million year-over-year, largely due to a reduction in impairment charges, which were $0 in the latest quarter compared to $510 million in the previous year. Selling, general, and administrative expenses also decreased by 8.3% to $1.504 billion, reflecting cost-saving measures and a reduction in separation-related costs. The company’s gross profit margin slightly declined to 58.9% from 59.1%, influenced by net input cost inflation and strategic pricing investments.

Kenvue's strategic initiatives included the ongoing 2024 Multi-Year Restructuring Initiative aimed at enhancing operational efficiencies and optimizing costs. The company incurred restructuring expenses of $60 million during the quarter, up from $48 million a year earlier. The restructuring is expected to yield annualized gross cost savings of approximately $350 million starting in fiscal year 2026. Additionally, Kenvue has been focusing on its digital strategy to better connect with consumers and enhance brand relevance.

Operationally, Kenvue's total assets increased to $27.132 billion as of June 29, 2025, compared to $25.601 billion at the end of the previous fiscal year. The company reported a cash and cash equivalents balance of $1.070 billion, unchanged from the previous period. Kenvue's employee headcount remained stable, and the company continues to monitor macroeconomic conditions, including potential impacts from global trade policies and tariffs, which could affect supply chain costs.

Looking ahead, Kenvue anticipates continued challenges in the market, particularly in the face of competitive pressures and changing consumer preferences. The company is committed to executing its strategic initiatives and leveraging its brand portfolio to drive growth. Kenvue's management remains optimistic about the potential for future profitability and market share recovery as it navigates these challenges.

About Kenvue Inc.

Kenvue is a global consumer health company specializing in trusted brands across self-care, skin health, beauty, and essential health categories. It offers over-the-counter medicines, personal care, and dermatological products to consumers worldwide. Leveraging science, innovation, and digital marketing, it focuses on everyday care, brand differentiation, and sustainable growth in diverse markets. Its business model emphasizes brand strength, consumer insights, and global supply chain resilience.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.